The safety and effects of the beta-blocker, nadolol, in mild asthma: An open-label pilot study

ABSTRACT: Beta-blockers are currently contraindicated in asthma because their acute administration may be associated with worsening bronchospasm. However, their effects and safety with their chronic administration are not well evaluated. The rationale for this pilot study was based on the paradigm s...

Full description

Autores:

Parra, Sergio
Bond, Richard A.
Page, Clive
Shardonofsky, Felix
Hanania, Nicola A.
Singh, Supria
Eli Wali, Rami
Flashner, Michael
Franklin, Amie E.
Garner, William J.
Dickey, Burton F.
Ruoss, Stephen J.
O'connor, Brian J.

Tipo de recurso:

Article of investigation

Fecha de publicación:

2008

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/38204

Acceso en línea:

https://hdl.handle.net/10495/38204

Palabra clave:

Antagonistas Adrenérgicos beta - administración & dosificación
Adrenergic beta-Antagonists - administration & dosage
Antagonistas Adrenérgicos beta - efectos adversos
Adrenergic beta-Antagonists - adverse effects
Asma - tratamiento farmacológico
Asthma - drug therapy
Relación Dosis-Respuesta a Droga
Dose-Response Relationship, Drug
Femenino
Female
Masculino
Male
Persona de Mediana Edad
Middle Aged
Nadolol - administración & dosificación
Nadolol - administration & dosage
Nadolol - efectos adversos
Nadolol - adverse effects
Proyectos Piloto
Pilot Projects
Estudios Prospectivos
Prospective Studies
Pruebas de Función Respiratoria
Respiratory Function Tests
https://id.nlm.nih.gov/mesh/D001249
https://id.nlm.nih.gov/mesh/D004305
https://id.nlm.nih.gov/mesh/D000319
https://id.nlm.nih.gov/mesh/D005260
https://id.nlm.nih.gov/mesh/D008297
https://id.nlm.nih.gov/mesh/D008875
https://id.nlm.nih.gov/mesh/D009248
https://id.nlm.nih.gov/mesh/D010865
https://id.nlm.nih.gov/mesh/D011446
https://id.nlm.nih.gov/mesh/D012129

Rights

openAccess

License

https://creativecommons.org/licenses/by-nc-nd/4.0/